首页>
外国专利>
GENETIC VARIANTS IN IL-6, P53, MMP-9 AND CXCR PREDICT CLINICAL OUTCOME IN PATIENTS WITH CANCER TREATED WITH ANTI-VEGF THERAPY
GENETIC VARIANTS IN IL-6, P53, MMP-9 AND CXCR PREDICT CLINICAL OUTCOME IN PATIENTS WITH CANCER TREATED WITH ANTI-VEGF THERAPY
展开▼
机译:IL-6,P53,MMP-9和CXCR的遗传变异预测抗癌治疗癌症患者的临床结果
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides compositions and methods for determining the likelihood of response or survival of cancer patients treated with anti-VEGF therapy. After determining if a patient is likely to be successfully treated, the invention also provides methods for treating the patients.
展开▼